AstraZeneca shares present an opportunity after strong Q3 results
The UK’s second-largest listed company by market cap (at the time of writing) presents an opportunity for investors after releasing…
89,877$
-0,46%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
Astrazeneca plant Milliardeninvestionen in USA - Attraktives Geschäftsumfeld
CAMBRIDGE (dpa-AFX) - Nur wenige Tage nach den richtungsweisenden US-Präsidentschaftswahlen hat der britisch-schwedische Pharmakonzern Astrazeneca dort milliardenschwere Investitionen angekündigt.…
AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat By Reuters
AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat…
AstraZeneca invests $3.5 billion in US
12 November 2024
AstraZeneca invests $3.5 billion
in R&D and manufacturing in the United States
AstraZeneca today announces $3.5 billion of capital investment…
Dato-DXd new BLA submitted, NSQ BLA withdrawn
12 November 2024
Datopotamab deruxtecan new BLA submitted for accelerated approval in the US for patients with previously treated advanced EGFR-mutated non-small…